Cite
HARVARD Citation
Baumgart, S. et al. (2020). Darolutamide antagonizes androgen signaling by blocking enhancer and super‐enhancer activation. Molecular oncology. 14 (9), pp. 2022-2039. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Baumgart, S. et al. (2020). Darolutamide antagonizes androgen signaling by blocking enhancer and super‐enhancer activation. Molecular oncology. 14 (9), pp. 2022-2039. [Online].